Skip to content

Safety evaluation of an excessive consumption of a plant-derived processed product

Safety evaluation of an excessive consumption of a plant-derived processed product - Safety evaluation a plant-derived processed product

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018506
Enrollment
40
Registered
2015-07-31
Start date
2015-07-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nothing (healty subject)

Interventions

C-001) 3 times of serving size per day for 4 weeks Test food (product code
A-001) 3 times of serving size per day for 4 weeks

Sponsors

QOLRD CORPORATION
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1, BMI>=18.5 and <30 kg/m2 2, BMI>=20 and <65 years-old 3, Person who provides informed consent by a document

Exclusion criteria

Exclusion criteria: 1, Person who is difficult to participate the study due to dysfunctions of liver, kidney, heart, respiration, endocrine secretion, metabolism, nervous system, consciousness or diabetes, or the other dysfunctions. 2, Person who takes medication for glucose or fat metabolism, or hypertension. 3, Person who was given surgery for a disease or an injury 2 months prior to the study. 4, Individual intakes supplements or the food for specific use of health authorized the government. 5, Person had allergy against any constituents in the test diet. 6, Person who is used to take test food. 7, Individual experienced unpleasant feeling during blood drawing. 8, Person who donated 200mL or more of blood within a month prior to the study. 9, Heavy smoker 10, Person who don't record of meal recoding for 9 days 11, Shift worker 12, Person who is planned long term business trip or travel of a domestic or foreign country in study priod 13, Person who can't accept to be accessed their medical records. 14, Person who have participated in other clinical studies. 15, Person who are expecting pregnancy or lactation period. 16, Person who are considered inappropriate by medical doctors.

Design outcomes

Primary

MeasureTime frame
Safety evaluation (repeated ingestion for 4 weeks) physical examination blood general analysis biochemical test urinalysis

Countries

Japan

Contacts

Public ContactYuri Agawa

QOLRD CORPORATION CRO Department

y-agawa@qol-rd.co.jp03-6386-8809

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026